Workup for Inflammatory Bowel Disease (IBD)
A workup for Inflammatory Bowel Disease (IBD) should be initiated in this case based on clinical presentation, as early diagnosis significantly impacts morbidity, mortality, and quality of life outcomes. 1
Diagnostic Approach for IBD
Initial Assessment
- Clinical symptoms requiring IBD workup:
- Persistent diarrhea
- Rectal bleeding
- Abdominal pain (especially right lower quadrant or periumbilical)
- Urgency and tenesmus
- Systemic symptoms (fever, weight loss, fatigue)
- Extraintestinal manifestations (joint pain, skin lesions, eye inflammation)
- Family history of IBD
Laboratory Evaluation
First-line tests:
- Complete blood count (anemia suggests chronic disease)
- Acute phase reactants:
- C-reactive protein (CRP) - increases within 6-8 hours of inflammation onset 2
- Erythrocyte sedimentation rate (ESR) - increases more slowly (24-48 hours) 2
- Fecal calprotectin - critical for differentiating IBD from IBS 2
- <100 μg/g: IBD unlikely
- 100-250 μg/g: Consider repeat testing or routine referral
250 μg/g: Urgent referral to gastroenterology
Additional testing:
- Stool studies to rule out infectious causes
- Liver function tests
- Albumin (marker of nutritional status and inflammation)
Endoscopic Evaluation
- Ileocolonoscopy with biopsies is the reference standard for IBD diagnosis 2
- Biopsies should be taken from both inflamed and uninflamed segments
- Helps distinguish between Crohn's disease and ulcerative colitis
Imaging Studies
- Cross-sectional imaging:
- CT enterography or MR enterography for small bowel assessment
- Particularly important for suspected Crohn's disease with small bowel involvement
Decision Algorithm for IBD Workup
Evaluate for alarm symptoms:
- Persistent rectal bleeding
- Nocturnal symptoms
- Weight loss >10%
- Family history of IBD or colorectal cancer
- Anemia
- Elevated inflammatory markers
If alarm symptoms present:
- Proceed directly to endoscopic evaluation
- Order fecal calprotectin
If no alarm symptoms but persistent GI symptoms:
- Check fecal calprotectin
- If >100 μg/g, proceed to endoscopic evaluation
- If <100 μg/g, consider alternative diagnoses (IBS)
Multidisciplinary Management
- IBD workup and management should involve both gastroenterologists and surgeons 1
- Early involvement of a multidisciplinary team improves outcomes, especially in complex cases
Important Considerations
- Avoid delays in diagnosis: Patients with IBD may previously receive incorrect diagnoses of irritable bowel syndrome, particularly those under 40 years of age 3
- Recognize extraintestinal manifestations: Up to 24% of patients with IBD present with extraintestinal manifestations before intestinal symptoms appear 4
- Infection risk: Be aware of increased infection risk in IBD due to both the disease itself and potential treatments 3
Pitfalls to Avoid
- Relying solely on clinical symptoms without objective markers (calprotectin, CRP)
- Incomplete endoscopic assessment (failing to examine terminal ileum)
- Inadequate biopsies (not sampling both inflamed and uninflamed tissue)
- Missing indeterminate colitis cases that don't clearly fit Crohn's or UC patterns 5
By following this structured approach to IBD workup, you can ensure timely diagnosis and appropriate management, which directly impacts patient morbidity, mortality, and quality of life.